Executives
-
Robert B. FordChairman of the Board and Chief Executive Officer -
Robert E. Funck Jr.Executive Vice President -
Philip P. BoudreauSenior Vice President -
Hubert L. AllenExecutive Vice President -
Lisa D. EarnhardtExecutive Vice President and Group President -
Daniel G. SalvadoriExecutive Vice President and Group President -
Allen Hubert LEXECUTIVE VICE PRESIDENT -
Ford Robert BCHAIRMAN AND CEO
-
Boudreau Philip PEXECUTIVE VICE PRESIDENT
-
Mccoy John A. Jr.VICE PRESIDENT
-
Morrone Louis H.EXECUTIVE VICE PRESIDENT
-
Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENT
-
Earnhardt Lisa DEXECUTIVE VICE PRESIDENT
-
Wainer Andrea FEXECUTIVE VICE PRESIDENT
-
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENT
-
Moreland Mary KEXECUTIVE VICE PRESIDENT
Board Directors
-
R. J. AlpernDirector
-
C. Babineaux-FontenotDirector
-
S. E. BlountDirector
-
P. GonzalezDirector
-
M. A. KumbierDirector
-
D. W. McDewDirector
-
N. McKinstryDirector
-
M. G. OGradyDirector
-
W. A. OsbornDirector
-
M. F. RomanDirector
-
D. J. StarksDirector
-
J. G. StrattonDirector
-
G. F. TiltonDirector
-
Stratton John GDirector
-
Roman Michael FDirector
-
Gonzalez Patricia PaolaDirector
-
Alpern Robert JDirector
-
Starks Daniel JDirector
-
O'Grady MichaelDirector
-
Mckinstry NancyDirector
-
Mcdew Darren WDirector
-
Kumbier MichelleDirector
-
Blount Sally E.Director
-
Babineaux-Fontenot ClaireDirector
?
Roman Michael F
Director
Abbott Laboratories
US, North Chicago [HQ]
CIK
1577544
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
1,755,715,568
Price per Share :
$139.18
Equivalence :
$244,360,492,754.24
Transaction History
-
S1,755,715,568 Shares After TransactionValue : $216,743,086,869.60Sold $510,959.55Transaction Date : 08/07/24
-
Footnotes
-
-
Footnotes:#1 Includes dividend share equivalents, accrued quarterly, pursuant to 3M's Deferred Compensation Plan.
-
S1,749,605,568 Shares After TransactionValue : $216,006,303,425.28Sold $75,434.06Transaction Date : 08/07/24
-
Footnotes
-
-
Footnotes:#1 Includes dividend share equivalents, accrued quarterly, pursuant to 3M's Deferred Compensation Plan.
-
S1,745,175,568 Shares After TransactionValue : $215,476,827,380.96Sold $54,697.21Transaction Date : 08/07/24
-
Footnotes
-
-
Footnotes:#1 Includes dividend share equivalents, accrued quarterly, pursuant to 3M's Deferred Compensation Plan.
-
S1,740,355,568 Shares After TransactionValue : $214,899,105,536.64Sold $59,517.36Transaction Date : 08/07/24
-
Footnotes
-
-
Footnotes:#1 Includes dividend share equivalents, accrued quarterly, pursuant to 3M's Deferred Compensation Plan.
-
A1,583,122,602 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/05/24
-
Footnotes
-
-
Footnotes:#1 Represents shares of 3M common stock that will be delivered pursuant to the terms of a performance share award made to the reporting person on March 1, 2021. The performance-based vesting requirements applicable to such award were satisfied on the date reported in Column 2 above, which represents the date on which the level of performance attained was certified. The reporting person previously elected to defer receipt of the shares and will not have voting or investment powers with respect to such shares until they are issued.#2 Includes dividend share equivalents, accrued quarterly, pursuant to 3M's Deferred Compensation Plan.#3 Includes shares acquired under 3M's General Employee Stock Purchase Plan.#4 The number of shares withheld for taxes was estimated and will be revised by amendment if necessary.